When 96372 Errors Led to Denials and How We Fixed Them

Infusion billing teams process hundreds of claims daily. 96372 is one of the most often miscoded and misunderstood codes in the outpatient and infusion setting, among all the codes that are denied. One missing document, one incorrect modifier or one missed payer requirement can return an entire claim with a denial.

This is a real case study for this blog. It covers the exact errors that caused 96372 denials in our billing operation, the root cause of each error and the specific action we took to correct each error. This guide is for your team if you’re seeing the following denials again and again.

 

What Is CPT Code 96372?

CPT code 96372 indicates a therapeutic, prophylactic or diagnostic injection that is given subcutaneously or intramuscularly. It is used for direct injection of a drug or substance into the tissue under the skin or into the muscles. This code is commonly used in physician offices, infusion centers and other outpatient sites to administer other types of injectable medications, including vitamin B12, testosterone, methotrexate and many others.

In-vid intravenous push or infusion is not covered by 96372. It is not applicable to chemotherapy injections, where there are codes dedicated to those. The first step to billing this code properly is to know the limitations of this code.

 

Error 1: Missing or Incomplete Medical Necessity Documentation

No payment will be accepted where there is no evidence of the services in the medical record. Additionally, 96372 claims were submitted with no strong documentation of the need for the injection, but were denied. These clinical notes were either too short, the diagnosis codes were not clearly related to the drug ordered or the chart just didn’t mention anything about the injection being ordered.

Root Cause

• Diagnosis codes did not match the drug given
• Clinical notes lacked the reason for the injection
• No physician order was linked to the injection visit
• Coders submitted claims without reviewing chart notes

How We Fixed It

• Built a documentation checklist for every 96372 encounter
• Required a matching diagnosis code for each injectable drug
• Made clinical note review a mandatory step before coding
• Trained coders to flag incomplete notes before submission

 

Error 2: Billing 96372 Alongside Infusion Codes on the Same Day

Many patients come in for an infusion and also receive a separate injection during the same visit. This is a legitimate clinical scenario. However, when 96372 was billed on the same claim as infusion codes like 96365 or 96413 without the right modifier, payers bundled the injection into the infusion payment and denied this code as a duplicate service.

Root Cause

• Modifier 59 or XS was not added to this code
• No separate documentation for the injection service
• Coders assumed payers would separate the services
• Claim edits were not set up to catch this bundling issue

How We Fixed It

• Added modifier 59 or XS to this code on same day claims
• Required a separate clinical note for each injection
• Set up claim scrubbing rules to catch missing modifiers
• Educated coders on when bundling edits apply to 96372

 

Error 3: Incorrect Place of Service on the Claim

Place of service is not just a box on the claim form. It determines how payers process the claim and what payment rules apply. When this code was billed under the wrong place of service, such as submitting it as an outpatient hospital service instead of an office visit, claims were denied automatically. Medicare and commercial payers both have strict place of service requirements for this code.

Root Cause

• Claims submitted with wrong place of service code
• Billing staff did not verify POS before submission
• No automated check was in place to catch POS errors
• Payer specific POS rules were not documented internally

How We Fixed It

• Audited all 96372 claims by place of service code
• Cross referenced each payer’s POS billing guidelines
• Set up billing software rules to flag POS mismatches
• Updated the billing team training on POS requirements

 

Error 4: Supervision Requirement Not Documented

Medicare and many commercial payers require that a physician be directly supervising the administration of a therapeutic injection when 96372 is billed. In several cases, claims were submitted without any documentation showing who supervised the service. In other situations, the injection was given by a nurse or medical assistant without a physician present on site, which violated supervision rules.

Root Cause

• Supervising provider name missing from the claim
• Physician was not on site during the injection
• Staff was unaware of supervision billing requirements
• No internal policy existed to enforce supervision rules

How We Fixed It

• Documented the supervising provider on every 96372 claim
• Reviewed each payer’s supervision policy for injections
• Trained clinical and billing staff on supervision rules
• Created an internal policy requiring physician presence

 

Error 5: Duplicate Billing With Chemotherapy Injection Codes

Codes 96372 and chemotherapy injection codes (96401 and 96402) are not interchangeable, and are not eligible to be billed together for the same injection. Some coders have billed both this code and 96401 for the same claim line when a patient was administered a chemotherapy drug intramuscularly. This was reported as duplicate billing by the payers and denied by either or both payers.

Root Cause

• Coders did not know 96372 and 96401 are mutually exclusive
• No claim editing rule existed to catch this combination
• Drug type was not verified before selecting the admin code
• Training did not cover chemotherapy vs therapeutic codes

How We Fixed It

• Added a claim scrubbing rule to block 96372 with 96401
• Created a training module on chemotherapy code differences
• Required drug type verification before selecting admin code
• Audited past claims to identify and correct past duplicates

 

Error 6: Missing or Unsigned Physician Order

All injections billed under this code require a physician order or prescription. For payer audits, several claims were looked at, and orders were either missing from the chart, not signed by the physician, or documented later in the services provided. This resulted in denial of not only the specific claims but also the review of the account. This led to denial of not only those claims, but the account itself.

Root Cause

• Orders were missing from the chart at time of billing
• Some orders were unsigned or had incorrect dates
• Billing proceeded without confirming order completion
• EHR did not have a verification step for signed orders

How We Fixed It

• Created an order confirmation flag inside the EHR system
• Blocked billing workflow until a signed order was confirmed
• Trained clinical staff to complete orders before injection
• Set a rule requiring order dates to match service dates

 

Error 7: Using 96372 for the Wrong Drug or Route

Not every subcutaneous or intramuscular injection should be billed under 96372. Some drugs have their own specific HCPCS administration codes. Other drugs may require a different CPT code based on payer policy or the clinical nature of the drug being administered. When coders defaulted to this code for every injection without checking the specific drug requirements, denials followed.

Root Cause

• Coders defaulted to 96372 for all injection types
• No drug to code mapping reference guide was available
• HCPCS specific drug codes were overlooked during coding
• Payer specific injection rules were not being followed

How We Fixed It

• Built a drug to code mapping guide for common injectables
• Required coders to verify the guide before final submission
• Added payer specific injection rules to the coding workflow
• Reviewed and updated the drug mapping guide quarterly

 

Key Takeaways for Infusion Billers

Documentation is the most crucial element to success with getting 96372 paid first time. The claim will not have the advantage of a clear clinical note, a matching diagnosis, and a signed physician order.

Payer specific rules for supervision, place of service and drug specific coding must be understood. Each Medicare, Medicaid, and commercial payer has their own set of rules, and the billing team needs to be educated on each rule.

Claim scrubbing tools are great, but only as good as the rules programmed into them. A significant portion of denials can be prevented before leaving the practice by taking the time to establish the proper edits, modifier requirements, and mutually exclusive codes for 96372 bundling.

An 96372 claims audit is a proactive approach for detecting errors before they are identified by payers, and can be performed on a regular basis. The billing process will be clean and compliant through a quarterly review of denial patterns, documentation quality and coder accuracy.

 

How Infusion Billing Services Gets 96372 Right the First Time

Infusion Billing Services focuses on the billing and coding requirements of infusion centers and injection practices. Our team has in-depth knowledge of the payer specific rules, documentation requirements and coding guidelines that directly affect the reimbursement for code 96372. We don’t wait for denials to locate the problems. From the beginning, we develop claim processes that are clean, utilizing proven claim checklists, claim scrubbing tools and continually educating our coders. If you have 96372 denials in your practice, we can audit your claims, figure out what is causing them and then you can make some changes that will last a long time. We will take care of your billings, while you focus on the patients!

 

Conclusion

96372 is a standard code, not a simple code! The errors listed in this case study illustrate how easily a valid service can be denied because of missing documentation, coding or workflow issues.

The bright side of this is that all of these errors were correctible. By implementing proper documentation standards, educating coders, establishing claim-editing rules and workflow checkpoints, this code denials can be drastically lowered or completely avoided.

The first step in resolving the issue if your infusion billing team is encountering frequent denials for 96372 is to run an audit on claims from the past 90 days. Search for patterns in the reasons of denial. Next use this case study as a blueprint for developing your own fixes that your operation requires. Clear process is the starting point of clean claims and that’s what this work is about.